Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
Recruiting · NCT05065801 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2026-04-15 | NCT05065801 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut du Cancer de Montpellier - Val d'Aurelle | 67 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Catalan d'Oncologie | Perpignan | France | 1 |
| Centre Georges-François Leclerc | Dijon | France | 15 |
| CH de Perpignan | Perpignan | France | 1 |
| CHU Grenoble | Grenoble | France | 1 |
| CHU St Eloi | Montpellier | France | 1 |
| CHU St Etienne | Saint-Etienne | France | 1 |
| Institut GODINOT | Reims | France | 1 |
| Institut régional du Cancer de Montpellier | Montpellier | France | 9 |